Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Janux Therapeutics (JANX) Return on Equity (2021 - 2025)

Historic Return on Equity for Janux Therapeutics (JANX) over the last 5 years, with Q3 2025 value amounting to 0.1%.

  • Janux Therapeutics' Return on Equity fell 100.0% to 0.1% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.1%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.1% for FY2024, which is 700.0% up from last year.
  • Per Janux Therapeutics' latest filing, its Return on Equity stood at 0.1% for Q3 2025, which was down 100.0% from 0.11% recorded in Q2 2025.
  • In the past 5 years, Janux Therapeutics' Return on Equity registered a high of 0.05% during Q3 2021, and its lowest value of 0.22% during Q2 2023.
  • Over the past 5 years, Janux Therapeutics' median Return on Equity value was 0.11% (recorded in 2024), while the average stood at 0.13%.
  • As far as peak fluctuations go, Janux Therapeutics' Return on Equity plummeted by -1200bps in 2022, and later soared by 1500bps in 2024.
  • Over the past 5 years, Janux Therapeutics' Return on Equity (Quarter) stood at 0.09% in 2021, then tumbled by -120bps to 0.19% in 2022, then rose by 13bps to 0.17% in 2023, then skyrocketed by 51bps to 0.08% in 2024, then fell by -26bps to 0.1% in 2025.
  • Its last three reported values are 0.1% in Q3 2025, 0.11% for Q2 2025, and 0.08% during Q1 2025.